[Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment].
Bernat
S
S
Gozalbo
T
T
García-Boyero
R
R
Guinot
M
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D003907:Dexamethasone / Q000008:administration & dosage; D018450:Disease Progression; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D009194:Myeloma Proteins / Q000032:analysis*; D009915:Orbit / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D013131:Spine / Q000473:pathology
D009194:Myeloma Proteins; D003907:Dexamethasone; D008558:Melphalan; D011241:Prednisone
Mieloma con extensión extramedular coincidiendo con la normalización de la paraproteińa sérica tras tratamiento.